|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gorzata Palczewska1,2
nicki1,6
1 Department of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology, Warsaw, Poland
2 Centro Nacional de Biotecnologia CSIC, Campus de la Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain
3 Research Group for Antibiotics of the Hungarian Academy of Sciences and Department of Pharmaceutical Chemistry, University of Debrecen, Debrecen, Hungary
4 Centro de Investigaciones Biológicas, Madrid, Spain
5 Department of Biophysical Chemistry, University of Lund, Lund, Sweden
6 International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland
Reprint requests to: Patrick Groves, Centro de Investigaciones Biológicas, Calle Ramiro de Maeztu 9, 28040 Madrid, Spain; e-mail: pdgroves{at}cib.csic.es; fax: +34-915627518.
(RECEIVED January 18, 2005; FINAL REVISION March 29, 2005; ACCEPTED April 11, 2005)
| Abstract |
|---|
|
|
|---|
Keywords: calcium; calretinin; calbindin D28k; EF-hand; ischemia; pH response
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051369805.
| Introduction |
|---|
|
|
|---|
pH-responsive elements have been reported in calcium-binding proteins inferred in disease states related to increased calcium and/or proton concentrations. Annexin VI has a well-defined calcium-dependent interaction with membranes at pH 7.2 (Bandorowicz-Piku
a et al. 1996). However, lower pH promotes a significant structural change, leading to the exposure of new hydrophobic surfaces and the integration into membranes with ion-channel formation (Golczak et al. 2001). These latter properties have been linked to Annexin VI function in endo/exocytosis (Golczak et al. 2001). A second example is calcium-binding brain nitric oxide synthase (NOS) in Carassius auratus (Conte 2003). The NOS activity of this protein is lowered 14-fold between pH 7.2 and pH 6.8 (Conte 2003), and this can be compensated by increased calcium concentrations. A third example is calbindin D28k (CB) for which a pH-responsive element has been identified in the N-terminal half of the protein (Berggård et al. 2000a). CB activates myo-inositol monophosphatase (IMPase) and is a more potent activator at reduced pH (Berggård et al. 2002b). Increased CB protein levels protect against ischemic insult, either when induced before an ischemic event (Yenari et al. 2001) or when induced within a short period after an ischemic event (Phillips et al. 2001). As CB also has the potential to be nitrosylated (Tao et al. 2002) or phosphorylated (Gagnon and Welsh 1997), it is possible that CB has a multifactor response to ischemia.
Calretinin (CR) is a calcium-binding protein homologous to CB (59% identical), calbindin-32 (42% identical), and secretagogin (38% identical). These EF-hand proteins are characterized by six helix-loop-helix EF-hand motifs with distinct, predominantly neuronal localizations (Celio 1996; Wagner et al. 2000; Gartner et al. 2001). Despite the relationship, the domain organizations of CR and CB appear to be different (Linse et al. 1997; Berggård et al. 2000b; Palczewska et al. 2003). CB contains a single domain of six EF-hands, while CR consists of two independent domains (consisting of EF-hand motifs I and II, residues 1100, termed CR III; and EF-hand motifs III VI, residues 100271, termed CR IIIVI) (Palczewska et al. 2003). CR interacts with cytoskeleton components in a calcium-dependent manner (Marilley and Schwaller 2000). Biochemical experiments have indicated that CR possesses calcium-dependent hydrophobic surfaces but, in contrast to calmodulin (Zhang et al. 1995), calcium-free (apo) CR also displays a significant hydrophobic surface (Ku
nicki et al. 1994; Schwaller et al. 1997). Immunohistochemical studies indicate that CR-containing cells are protected against cell death in several neurodegenerative diseases (Fonseca and Soriano 1995; Liang et al. 1996) and ischemia (Kawai et al. 1995; Andsberg et al. 2001). However, other studies suggest CR-containing cells are more vulnerable to ischemia (Freund and Magloczky 1993; Hsu et al. 1994; Yamada et al. 1995; Arabadzisz and Freund 1999). CR may also act as a calcium buffer (Schwaller et al. 1997; Billing-Marczak and Ku
nicki 1999) and its biological role may vary over cell type.
In the present work we investigate the structural modulation of CR by changes in pH over the physiological range. pH effects on hydrophobic surfaces are found for calcium-bound CR. Isolated CR domains are used to localize a major calcium-dependent, pH-responsive element to CR III and nuclear magnetic resonance spectroscopy (NMR) data identifies the regions of the domain that might be involved in the process.
| Results |
|---|
|
|
|---|
|
|
0.1 ppm, 11 of 15 13C chemical shift differences
0.5 ppm, and four of six 15N chemical shift differences
0.5 ppm originate in the N-loop and first EF-hand region (residues 1353) of CR III (Fig. 3BD
|
|
|
| Discussion |
|---|
|
|
|---|
nicki et al. 1995) and TNS fluorescence (Schwaller et al. 1997). Calcium modulated the exposed hydrophobic surfaces of the protein. Here we further investigate hydrophobic properties as a function of pH for intact CR as well as its independent domains, CR III and CR IIIVI (Palczewska et al. 2003). Conditions were chosen so that the proteins would be maintained in a calcium-free or bound state at all pH values, taking into account the pH-dependent Ca2+-affinities for EGTA (Bers 1982) and the proteins (Stevens and Rogers 1997). Combinations of 10 µM calcium and 1 mM EDTA provided data for CR III in the pH range 6.07.3 in separate experiments that are consistent with the data in Figure 1E
Detailed studies on calbindin D9k over a range of pH show that affinity of its calcium-binding sites are lowered 10-fold between pH 7 and pH 6 (Kesvatara et al. 2001). CR, similarly to calbindin D9k and Calb, has a submicromolar affinity for calcium at neutral pH (Ku
nicki et al. 1995; Stevens and Rogers 1997; Kesvatara et al. 2001; Berggård et al. 2002a). While we would expect CR III (and CR) to retain its submicromolar affinity for calcium in the pH-sensitive range (pH 6.77.7) as suggested by NMR experiments (Figs. 3
5![]()
), it is possible that any existing pH-dependent function will be lost under more extreme conditions. In this context, our biochemical data might explain the opposing conclusions relating the effects of calretinin on ischemia (Freund and Magloczky 1993; Hsu et al. 1994; Kawai et al. 1995; Yamada et al. 1995; Arabadzisz and Freund 1999; Andsberg et al. 2001). The calcium, proton effects of CR III might provide a spatial function, being activated in regions of the cell that experience high concentrations of calcium and protons. The complex role and response of calretinin in the formation of local calcium effects has been recently studied (Dargan et al. 2004). Also, it is known that the pH at the surface of phosphatidylcholine micelles can be lowered by 1.6 pH units (van der Goot 1991).
Both CR III and CR IIIVI induce higher TNS fluorescence, as pH is lowered from 7 to 6, suggesting that they become more hydrophobic. However, at pH 7, the much lower TNS intensity in the presence of CR III than CR IIIVI may indicate a weaker interaction with TNS and/or smaller hydrophobic surface of the N-terminal domain at neutral pH. It therefore appears that a drop in pH serves as a switch for Ca-bound CR III, while for Ca-bound CR IIIVI it only modulates an already significant hydrophobic surface.
The sensitivity of calcium-bound CR III to pH appears to depend on the employed experimental method. NMR provides direct residue-by-residue measurements, whereas detection by octyl-Sepharose chromatography and TNS fluorescence, important to link the pH effects to changes in hydrophobic surfaces, rely on the binding of nonnative ligands to the protein. Therefore, the pH sensitivity of calcium-bound CR III for its targets or function is more likely to occur around physiological pH 7.2 as reported by the NMR titration (Figs. 4
, 5
), confirmed to be between pH 6.7 and pH 7.7 by NMR assignments on a separate sample (Fig. 3
), as well as supported by the pH-response reported by octyl-Sepharose chromatography data (Fig. 2
) rather than around pH 6 as reported by TNS fluorescence (Fig. 1
). A similar behavior was reported for Annexin VI: The proteins pH-dependent hydrophobic surface is significant enough to allow integration into asolectin membranes and formation of ion channels at pH 5.3 but TNS detects the hydrophobic surface only at pH 4.5 (Golczak et al. 2001). At the same time, Calb has a contrasting behavior with its pH-dependent ANS-binding properties mirroring its IMPase activating potential (Berggård et al. 2000a, 2002b). This may be explained by the fact that ANS has a slightly different chemical structure to TNS; however, it is interesting that IMPase and caspase-3 (Bellido et al. 2000; Berggård et al. 2002b) have been shown to be Calb targets that do not bind CR.
In the present work, we have compared the pH 6.7 and 7.7 assignments (Fig. 3
), and these data have been complemented with a 15N1H-HSQC titration between pH 8.5 and 5.2 (Figs. 4
, 5
). The titration data (Fig. 4
) are consistent with the assignment (Fig. 3
) in that the absolute changes in chemical shifts for each residue are similar for both sets of data. Both data sets suggest local changes close to the histidine residues with the second EF-hand of CR III relatively unaffected by pH. The most affected region comprises the last four residues (1216) of the N-terminal loop and a large fraction of helix A (residues 1729) (Figs. 3
, 5B
). This region includes two His residues (His12 and His27) and the N-terminal capping motif of helix A (Thr17Gln20). A second affected region is found in the middle of helix B (spanning residues 4451). Significantly smaller pH induced shift changes are observed in EF-hand II. However, the residues of EF-hand II that do experience pH-induced chemical shift changes are most likely to be close in space to His12 or His27. Based on 3D structures of other EF-hand pair domains, we may anticipate that EF-hands I and II pack against one another in an anti-parallel fashion with the two calcium loops next to each other. The N termini of helices A and C would be at the opposite end of the molecule in proximity to the C termini of helices B and D. The possible involvement of residues in the structurally unassigned linker regions cannot be addressed. The NMR data reveal no pH induced changes in secondary structure.
Figure 5A
indicates a common transition midpoint of pH 7.2 for the resonances displaying the largest shift changes. This suggests that the domain undergoes a concerted response to a single protonation event, or to parallel events involving groups with closely similar pKa values. Although elevated pKa values of glutamates up to 6.6 have been observed in the calcium-binding region of calbindin D9k (Kesvatera et al. 2001), His12 and His27 are the residues that are most likely to have pKa values close to 7.2. The occurrence of large chemical shift effects close to both histidines suggests that they both become protonated during the titration.
The hydrophobic properties of CR are quite different from those of the calcium sensor protein calmodulin. In the absence of calcium, calmodulin is often referred to as "closed," as it displays no hydrophobic surface. Calcium binding involves a significant rearrangement of the hydrophobic core leading to an "open" state that is hydrophobic and interacts with cellular targets, or with hydrophobic probes (Fig. 1C
). In this terminology, intact CR would be referred to as more or less open under all conditions. However, both calcium binding and pH variation for the calcium bound state modulate the hydrophobic surface, and may be a means to regulate the interaction between CR and its targets. Within CR III, only very modest pH-induced chemical shift changes are observed for side chain (H
and C
) resonances of expected hydrophobic core residues (W25 and F28) in CR III (Fig. 3
). This suggests that the pH-induced transition leading to increased hydrophobic surface does not involve any significant structural rearrangements of the hydrophobic core. We can conclude that the open, low pH Ca-bound CR III domain is likely to be different to the open structure of Ca-bound calmodulin in which the hydrophobic core is largely exposed and rearranged (Finn and Forsen 1995). The open, Ca-bound structures of recoverin (Flaherty et al. 1993) and dimeric S100s (Drohat et al. 1998) are known to be distinct to calmodulin with the retention of a hydrophobic core. Therefore, the low pH Ca-bound structure of CR III may be more related to the calcium switches observed in recoverin or S100 proteins than in calmodulin.
To summarize, the NMR measurements support a model by which protonation of His12 and/or His27 leads to a structural rearrangement that primarily involves residues at the junction of N-terminal loop and helix A (residues 1520) and the middle of helix B (residues 4451). The rearrangement produces a hydrophobic cavity, presumably at the base of the EF-hand domain, without any large-scale rearrangements of the hydrophobic core.
| Materials and methods |
|---|
|
|
|---|
nicki et al. (1995). 15N-labeled CR III was prepared from a Pichia pastoris expression system according to Palczewska et al. (2001).
Fluorescence spectroscopy
2-(p-Toluidino)-6-naphthalenesulfonic acid (TNS) fluorescence emission spectra were collected for CR in the presence of 1 mM EGTA or 0.1 mM CaCl2 on a Fluorolog 3 spectrometer (Jobin Yvon-Spex) at a temperature of 20°C (Neslab RTE-300 temperature control unit). Parameters were
ex=328 nm;
em scanned between 390 and 510 nm; and slits of 5 and 1.4 nm. The buffer was 50mMTris, 100mMKCl (pH68), supplemented with 30 µM TNS (Sigma). Sample volumes of 0.5 mL and protein concentrations (CR, CR III, CR IIIVI, and calmodulin, as reference) of 1 µM were used. The spectra of TNS, with a low intensity maximum of 488 nm, were unaffected by pH, EGTA, or CaCl2 additions. Spectra of TNS solutions were subtracted from the same TNS solutions containing protein. Experiments were performed in triplicate.
Phenyl-Sepharose chromatography
CR III (50 µL at 1 mg/mL supplemented with 1 M NaCl, 2 mM Tris [pH 7.0, 7.5, or 8.0]) was applied to a 1 mL phenyl- Sepharose (high-substitution) column (Amersham-Pharmacia). Data were collected using a BioLogic FPLC system (BioRad). The column was eluted with a decreasing NaCl gradient (1 M0 M) over 10 min in 2 mM Tris buffer (pH 7.0, 7.5, or 8.0). Following 10 min elution with 0 M NaCl buffer, the elution conditions were changed to H2O (10 min). All samples and buffers were supplemented with either 1 mM EGTA or 1 mM CaCl2. Control experiments were performed with 50 µg TR2C (calmodulin residues 77149) at pH 7.0. Absorbance (280 nm) and conductivity were simultaneously monitored. All runs were performed in triplicate.
NMR spectroscopy
The chemical shift difference (
) between the pH 7.7 and 6.7 was calculated for HN, HA, HB, CA, CB, CO, and NH resonances using published assignments of calcium-bound CR III (Palczewska et al. 2001) (BMRB entry 5156
[BMRB]
). These assignments were obtained for 1 mM 13C,15N-labeled CR III in 50 mM Tris-d11 with 25 mM NaCl, 10 mM CaCl2, 0.03% NaN3, and 5% D2O. The Web version of SHIFTOR (H. Zhang and D. Wishart, http://redpoll.pharmacy.ualberta.ca/shiftor/) was used to calculate
and
angles from the assignment data.
A pH titration of 1 mM 15N-labeled CR III in 50 mM Tris-d11 and 50 mM acetic acid-d4 with 25 mM NaCl, 10 mM CaCl2, 0.03% NaN3, and 5% D2O was followed by HSQC. Spectra were recorded at pH 5.2, 6.1, 7.0, 7.5, and 8.5 analyzed in SPARKY (T.D Goddard and D.G. Kneller, University of California Regents, University of California, San Francisco) to transfer peak assignments through the pH titration.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Arabadzisz, D. and Freund, T.F. 1999. Changes in excitatory and inhibitory circuits of the rat hippocampus 1214 months after complete forebrain ischemia. Neuroscience 92: 2745.[CrossRef][Medline]
Bandorowicz-Piku
a, J., Sikorski, A.F., Bia
kowska, K., and Sobota, A. 1996. Interaction of annexins IV and VI with phosphatidylserine in the presence of Ca2+: Monolayer and proteolytic study. Mol. Membr. Biol. 13: 241250.[Medline]
Bellido, T., Huening, M., Raval-Pandya, M., Manolagas, S.C., and Christakos, S. 2000. Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J. Biol. Chem. 275: 2632826332.
Berggård, T., Silow, M., Thulin, E., and Linse, S. 2000a. Ca(2+)- and H(+)-dependent conformational changes of calbindin D(28k). Biochemistry 39: 68646873.[CrossRef][Medline]
Berggård, T., Thulin, E., Åkerfeldt, K.S., and Linse, S. 2000b. Fragment complementation of calbindin D28k. Protein Sci. 9: 10941208.
Berggård, T., Miron, S., Onnerfjord, P., Thulin, E., Akerfeldt, K.S., Enghild, J.J., Akke, M., and Linse, S. 2002a. Calbindin D28k exhibits properties characteristic of a Ca2+ sensor. J. Biol. Chem. 277: 1666216672.
Berggård, T., Szczepankiewicz, O., Thulin, E., and Linse, S. 2002b. Myoinositol monophosphatase is an activated target of calbindin D28k. J. Biol. Chem. 277: 4195441959.
Bers, D.M. 1982. A simple method for the accurate determination of free [Ca] in Ca-EGTA solutions. Am. J. Physiol. 242: C404C408.
Billing-Marczak, K. and Ku
nicki, J. 1999. CalretininSensor or buffer Function still unclear. Pol. J. Pharmacol. 51: 173178.[Medline]
Celio, M.R. 1996. Guidebook to the calcium-binding proteins. Sambrook & Tooze with Oxford University Press, Oxford, UK.
Conte, A. 2003. Physiologic pH changes modulate calcium ion dependence of brain nitric oxide synthase in Carassius auratus. Biochim. Biophys. Acta 1619: 2938.[Medline]
Dargan, S.L., Schwaller, B., and Parker, I. 2004. Spatiotemporal patterning of IP3-mediated Ca2+ signals in Xenopus oocytes by Ca2+-binding proteins. J. Physiol. 556: 447461.
Drohat, A.C., Baldisseri, D.M., Rustandi, R.R., and Weber, D.J. 1998. Solution structure of calcium-bound rat S100B(
) as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37: 27292740.[CrossRef][Medline]
Finn, B. and Forsen, S. 1995. The evolving model of calmodulin structure, function and activation. Structure 3: 711.[Medline]
Flaherty, K.M., Zozulya, S., Stryer, L., and McKay, D.B. 1993. Three-dimensional structure of recoverin, a calcium sensor in vision. Cell 75: 709716.[CrossRef][Medline]
Fonseca, M. and Soriano, E. 1995. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimers disease. Brain Res. 691: 8391.[CrossRef][Medline]
Freund, T.F. and Magloczky, Z. 1993. Early degeneration of calretinin-containing neurons in the rat hippocampus after ischemia. Neuroscience 56: 581596.[CrossRef][Medline]
Gagnon, A. and Welsh, J. 1997. Modulation and phosphorylation of calbindin-D28K correlates with protein kinase C activation. Biochem. Cell Biol. 75: 3340.[CrossRef][Medline]
Gartner, W., Lang, W., Leutmetzer, F., Domanovits, H., Waldhausl, W., and Wagner, L. 2001. Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca(2+)-binding protein. Cereb. Cortex 11: 11611169.
Golczak, M., Kicinska, A., Bandorowicz-Piku
a, J., Buchet, R., Szewczyk, A., and Piku
a, S. 2001. Acidic pH-induced folding of annexin VI is a prerequisite for its insertion into lipid bilayers and formation of ion channels by the protein molecules. FASEB J. 15: 10831085.
Hsu, M., Sik, A., Gallyas, F., Horvath, Z., and Buzsaki, G. 1994. Short-term and long-term changes in the postischemic hippocampus. Ann. N. Y. Acad. Sci. 743: 121139.[Abstract]
Kawai, K., Nowak Jr., T.S., and Klatzo, I. 1995. Loss of parvalbumin immunoreactivity defines selectively vulnerable thalamic reticular nucleus neurons following cardiac arrest in the rat. Acta Neuropathol. (Berl.) 89: 262269.[Medline]
Kesvatera, T., Jonsson, B., Telling, A., Tougu, V., Vija, H., Thulin, E., and Linse, S. 2001. Calbindin D(9k): A protein optimized for calcium binding at neutral pH. Biochemistry 40: 1533415340.[CrossRef][Medline]
Kourie, J.I. 2001. Mechanisms of amyloid
protein-induced modification in ion transport systems: Implications for neurodegenerative diseases. Cell Mol. Neurobiol. 21: 173213.[CrossRef][Medline]
Ku
nicki, J., Winsky, L., and Jacobowitz, D.M. 1994. Ca(2+)-dependent and independent interactions of calretinin with hydrophobic resins. Biochem. Mol. Biol. Int. 33: 713721.[Medline]
Ku
nicki, J., Strauss, K.I., and Jacobowitz, D.M. 1995. Conformational changes and calcium binding by calretinin and its recombinant fragments containing different sets of EF hand motifs. Biochemistry 34: 1538915394.[CrossRef][Medline]
Liang, C.L., Sinton, C.M., and German, D.C. 1996. Midbrain dopaminergic neurons in the mouse: Co-localization with Calbindin-D28K and calretinin. Neuroscience 75: 523533.[CrossRef][Medline]
Linse, S., Thulin, E., Gifford, L.K., Radzewsky, D., Hagan, J., Wilk, R.R., and Åkerfeldt, K.S. 1997. Domain organization of calbindin D28k as determined from the association of six synthetic EF-hand fragments. Protein. Sci. 6: 23852396.[Abstract]
Marilley, D. and Schwaller, B. 2000. Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr. Exp. Cell Res. 259: 1222.[CrossRef][Medline]
Matsuyama, S. and Reed, J.C. 2000. Mitochondria-dependent apoptosis and cellular pH regulation. Cell Death Differ. 7: 11551165.[CrossRef][Medline]
Palczewska, M., Groves, P., Ambrus, A., Kaleta, A., Kövér, K.E., Batta, G., and Ku
nicki, J. 2001. Structural and biochemical characterization of neuronal calretinin domain III (residues 1100); Comparison to homologous calbindin D28k domain III (residues 193). Eur. J. Biochem. 268: 62296237.[Medline]
Palczewska, M., Groves, P., Batta, G., Heise, B., and Ku
nicki, J. 2003. Calretinin and calbindin D28k have different domain organizations. Protein Sci. 12: 180184.
Phillips, R.G., Monje, M.L., Giuli, L.C., Meier, T.J., Yenari, M.A., Kunis, D., and Sapolsky, R.M. 2001. Gene therapy effectiveness differs for neuronal survival and behavioral performance. Gene Ther. 8: 579585.[CrossRef][Medline]
Schwaller, B., Durussel, I., Jermann, D., Herrmann, B., and Cox, J. 1997. Comparison of the Ca2+-binding properties of human recombinant calretinin-22k and calretinin. J. Biol. Chem. 272: 2966329671.
Shrode, L.D., Rubie, E.A., Woodgett, J.R., and Grinstein, S. 1997. Cytosolic alkalinization increases stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) activity and p38 mitogen-activated protein kinase activity by a calcium-independent mechanism. J. Biol. Chem. 272: 1365313659.
Stevens, J. and Rogers, J.H. 1997. Chick calretinin: Purification, composition, and metal binding activity of native and recombinant forms. Protein Expr. Purif. 9: 171181.[CrossRef][Medline]
Tao, L., Murphy, M.E., and English, A.M. 2002. S-nitrosation of Ca(2+)- loaded and Ca(2+)-free recombinant calbindin D28k from human brain. Biochemistry 41: 61856192.[CrossRef][Medline]
van der Goot, F.G., Gonzalez-Manas, J.M., Lakey, J.H., and Pattus, F. 1991. A "molten-globule" membrane-insertion intermediate of the pore-forming domain of colicin A. Nature 354: 408410.[CrossRef][Medline]
Wagner, L., Oliyarnyk, O., Gartner, W., Nowotny, P., Groeger, M., Kaserer, K., Waldhausl, W., and Pasternack, M.S. 2000. Cloning and expression of secretagogin, a novel neuroendocrine- and pancreatic islet of Langerhans-specific Ca2+-binding protein. J. Biol. Chem. 275: 2474024751.
Yamada, K., Goto, S., Oyama, T., Yoshikawa, M., Nagahiro, S., and Ushio, Y. 1995. Striatal cells containing the Ca(2+)-binding protein calretinin (protein 10) in ischemia-induced neuronal injury. Acta Neuropathol. (Berl.) 89: 172177.[Medline]
Yenari, M.A., Minami, M., Sun, G.H., Meier, T.J., Kunis, D.M., McLaughlin, J.R., Ho, D.Y., Sapolsky, R.M., and Steinberg, G.K. 2001. Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 32: 10281035.
Zhang, M., Tanakaw, T., and Ikura, M. 1995. Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat. Struct. Biol. 2: 758767.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |